Monte Rosa Therapeutics (GLUE) PT Raised to $37 at Piper Sandler
Tweet Send to a Friend
Piper Sandler analyst Edward Tenthoff raised the price target on Monte Rosa Therapeutics (NASDAQ: GLUE) to $37.00 (from $27.50) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
